Metropolitan Life Insurance Company (MetLife)’s Compass Therapeutics CMPX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,926	Closed	-$3.81K	–	455
2024 Q1	$3.81K	Buy	1,926 +804	+72%	+$1.59K	﹤0.01%	2264
2023 Q4	$1.75K	Sell	1,122 -4,054	-78%	-$6.32K	﹤0.01%	2322
2023 Q3	$10.2K	Hold	5,176	–	–	﹤0.01%	2198
2023 Q2	$16.5K	Buy	+5,176	New	+$16.5K	﹤0.01%	2033